Blog

Review on CPHI Worldwide for Contract R&D (CRAMS) and Scale-Up
Review on CPHI Worldwide for Contract R&D (CRAMS) and Scale-Up

Review on CPHI Worldwide for Contract R&D (CRAMS) and Scale-Up

November 03, 2023

 

CPHI Worldwide is one of the world's largest and most comprehensive pharmaceutical exhibitions. CPHI’s various events are held annually in various locations around the world.

CPHI Worldwide is a valuable event for companies looking for contract research and development (R&D) and scale-up services. The exhibition attracts a wide range of CROs, CMOs, and other service providers from all over the world.

In terms of contract R&D, CPHI Worldwide is a great place to find CROs with expertise in a wide range of areas, including CRAMS, drug discovery, chemistry research, custom chemistry contracts, toll manufacturing, clinical development, and regulatory affairs. Visitors to the exhibition can meet with representatives from CROs to discuss their specific needs and get quotes for services.

In terms of scale-up, CPHI Worldwide is a great place to find CMOs with the capacity and expertise to produce commercial quantities of pharmaceutical and fine chemical products. Visitors at the exhibition can meet with representatives from CMOs to discuss their specific needs and get quotes for the services.

Here are some of the benefits of attending CPHI Worldwide for contract R&D and scale-up:

  • Access to a wide range of service providers: CPHI Worldwide attracts a wide range of CROs, CMOs, and other service providers from all over the world. This allows visitors to compare different providers and find the best one for their needs.
  • Ability to meet with representatives from service providers face-to-face: CPHI Worldwide provides a unique opportunity to meet with representatives from service providers face-to-face. This allows visitors to ask questions, get more information about services, and build relationships with potential partners.
  • Opportunity to learn about the latest trends and technologies in contract R&D and scale-up: CPHI Worldwide features several educational sessions and workshops on the latest trends and technologies in contract R&D and scale-up. This allows visitors to stay up to date on the latest developments and learn how to improve their operations.

Here are some of the specific ways that CPHI Worldwide Barcelona was beneficial for Shree Ganesh Remedies Limited:

  • New CRAMS and toll manufacturing developments: CPHI Worldwide Barcelona was a great place to develop new CRAMS and toll manufacturing businesses with customers with the capacity and expertise to help Shree Ganesh Remedies Limited achieve its business goals.
  • Better Business Negotiations: By meeting with multiple service providers at CPHI Worldwide Barcelona, Shree Ganesh Remedies Limited was able to improve terms for CRAMS and toll manufacturing services.
  • Got the latest information on industry trends and technologies: CPHI Worldwide Barcelona featured several educational sessions and workshops on the latest trends and technologies in the pharmaceutical industry. This allowed Shree Ganesh Remedies Limited to stay up-to-date on the latest developments and learn how to improve its operations.
  • Built relationships with potential customers: CPHI Worldwide Barcelona was also a great place to build relationships with potential customers. Shree Ganesh Remedies Limited was able to meet with representatives from pharmaceutical companies, specialty fine chemical companies and other stakeholders in the industry to learn more about their needs and discuss how Shree Ganesh Remedies Limited could help them achieve their goals.

Overall, CPHI Worldwide Barcelona was a valuable event for companies like Shree Ganesh Remedies Limited that were looking for CRAMS, Scale-up and Toll manufacturing services. The exhibition provided a unique opportunity to meet with multiple service providers in one place, negotiate better rates and terms, get the latest information on industry trends and technologies, and build relationships with potential customers.